Literature DB >> 21455735

Use of antidepressant medications and risk of fracture in older women.

Susan J Diem1, Terri L Blackwell, Katie L Stone, Jane A Cauley, Teresa A Hillier, Elizabeth M Haney, Kristine E Ensrud.   

Abstract

Use of antidepressant medications has been associated with increased risk of fracture, but prior studies have been limited by incomplete control of confounders or a limited number of fractures. Use of antidepressant medications by 8,217 community-dwelling women aged 69 and older from a population-based prospective cohort study at four US clinical centers was assessed by interview at four examinations over a 10-year period, beginning in 1992-1994. Use was coded as a time-dependent variable. Incident fractures occurring after the initial medication assessment until July 2007 were confirmed by radiographic reports. Potential confounders were included in multivariable models and updated at each follow-up visit. Compared to nonusers of antidepressant medications, women using SSRIs experienced a higher risk of nonspine fracture in age-adjusted models (HR = 1.36, 95% CI 1.11-1.67) and in multivariable models controlling for potential confounders (HR = 1.30, 95% CI 1.04-1.62). SSRI use was not associated with an increased risk of first hip fracture (HR = 1.01, 95% CI 0.71-1.44) but was associated with an increased risk of wrist fracture (HR = 1.54, 95% CI 1.01-2.36). TCA use was associated with an increased risk of nonspine fracture in age-adjusted models, but in multivariable models this risk was attenuated. SSRI use was associated with a higher risk of any nonspine fracture, but not hip fracture, in this cohort of older women. TCA use was associated with a higher risk of nonspine fracture, but this association was in part explained by confounding factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21455735      PMCID: PMC3542967          DOI: 10.1007/s00223-011-9481-5

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  55 in total

1.  Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.

Authors:  Stuart J Warden; Alexander G Robling; Megan S Sanders; Michael M Bliziotes; Charles H Turner
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

2.  Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies.

Authors:  Sebastian Schneeweiss; Philip S Wang
Journal:  J Clin Psychopharmacol       Date:  2004-12       Impact factor: 3.153

3.  Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.

Authors:  M Bliziotes; A Eshleman; B Burt-Pichat; X-W Zhang; J Hashimoto; K Wiren; C Chenu
Journal:  Bone       Date:  2006-08-01       Impact factor: 4.398

4.  Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromsø Study.

Authors:  A J Søgaard; R M Joakimsen; A Tverdal; V Fønnebø; J H Magnus; G K R Berntsen
Journal:  Osteoporos Int       Date:  2004-12-24       Impact factor: 4.507

5.  Depressive symptoms and changes in body weight exert independent and site-specific effects on bone in postmenopausal women exercising for 1 year.

Authors:  Laura A Milliken; Jennifer Wilhelmy; Catherine J Martin; Nuris Finkenthal; Ellen Cussler; Lauve Metcalfe; Terri Antoniotti Guido; Scott B Going; Timothy G Lohman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-05       Impact factor: 6.053

6.  Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Osteoporos Int       Date:  2006-03-07       Impact factor: 4.507

7.  Effect of selective serotonin reuptake inhibitors on the risk of fracture.

Authors:  J Brent Richards; Alexandra Papaioannou; Jonathan D Adachi; Lawrence Joseph; Heather E Whitson; Jerilynn C Prior; David Goltzman
Journal:  Arch Intern Med       Date:  2007-01-22

8.  Predictors of non-spine fracture in elderly men: the MrOS study.

Authors:  Cora E Lewis; Susan K Ewing; Brent C Taylor; James M Shikany; Howard A Fink; Kristine E Ensrud; Elizabeth Barrett-Connor; Steven R Cummings; Eric Orwoll
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

9.  Depression and hip fracture risk: the NHANES I epidemiologic follow-up study.

Authors:  Michael E Mussolino
Journal:  Public Health Rep       Date:  2005 Jan-Feb       Impact factor: 2.792

10.  Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong).

Authors:  Samuel Y S Wong; Edith M C Lau; Henry Lynn; P C Leung; Jean Woo; Steve R Cummings; Eric Orwoll
Journal:  Osteoporos Int       Date:  2004-09-23       Impact factor: 4.507

View more
  17 in total

1.  Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose.

Authors:  P Vestergaard; D Prieto-Alhambra; M K Javaid; C Cooper
Journal:  Osteoporos Int       Date:  2012-06-06       Impact factor: 4.507

2.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

3.  SSRIs: bad to the bone?

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Innov Clin Neurosci       Date:  2012-07

4.  Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.

Authors:  C Zhou; L Fang; Y Chen; J Zhong; H Wang; P Xie
Journal:  Osteoporos Int       Date:  2018-02-12       Impact factor: 4.507

5.  Adherence to treatment with selective serotonin reuptake inhibitors and the risk for fractures and bone loss: a population-based cohort study.

Authors:  Inbar Zucker; Gabriel Chodick; Leon Grunhaus; Ra'anan Raz; Varda Shalev
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

6.  Rates of bone loss among women initiating antidepressant medication use in midlife.

Authors:  Susan J Diem; Kristine Ruppert; Jane A Cauley; YinJuan Lian; Joyce T Bromberger; Joel S Finkelstein; Gail A Greendale; Daniel H Solomon
Journal:  J Clin Endocrinol Metab       Date:  2013-09-03       Impact factor: 5.958

7.  Relationship between use of antidepressants and risk of fractures: a meta-analysis.

Authors:  V Rabenda; D Nicolet; C Beaudart; O Bruyère; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-05-26       Impact factor: 4.507

Review 8.  Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?

Authors:  Stuart J Warden; Robyn K Fuchs
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

9.  Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.

Authors:  M L O Shea; L D Garfield; S Teitelbaum; R Civitelli; B H Mulsant; C F Reynolds; D Dixon; P Doré; E J Lenze
Journal:  Osteoporos Int       Date:  2013-01-29       Impact factor: 4.507

Review 10.  Brains, bones, and aging: psychotropic medications and bone health among older adults.

Authors:  Monique J Brown; Briana Mezuk
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.